Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism

Alphabetical Test listing

Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism-994

  
Plasminogen activator inhibitor 1 (PAI-1) 4G/5G polymorphism
  
994
  
LAB994
  
MSO
  
Plasminogen activator inhibitor (PAI-1), Gene polymorphism
  

Deep vein thrombosis (DVT) and coronary artery disease (CAD) are associated with increased PAI-1 levels. Elevated PAI-1 levels may help predict risk of reinfarction in survivors of myocardial infarction, particularly in young individuals. PAI-1 levels tend to be lower in individuals with 4G/5G or 5G/5G genotype compared to a 4G/4G genotype.

  
EDTA whole blood
  
  
1.0 mL
  

Lavender (EDTA), 4mL

 

  
ACD whole blood
  

Yellow ACD (A or B)

 

  

Yellow ACD (A or B)

  

Ambient (preferred) - 8 days

Refrigerated - 8 days

  
Esoterix Coagulation Lab (129100) via LabCorp (500309): R-NX
  
Mo, Th
  
7 - 11 days
  

Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) technologies

  

An interpretive report will be provided

  
81400
  
Yes
  
  
Result UNLOINC
  
05/24/2019
  
05/24/2019
  
05/18/2020